Sayora Pharma Private Limited

Sayora Pharma Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U24211CH1988PTC008896 Incorporated 12 December 1988 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2024
₹2.23 Cr
▲ 16% YoY
Net profit · FY 2024
₹90,053
Net margin 0.4%
EBITDA · FY 2024
₹12.81 Lakh
EBITDA margin 5.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹4.53 Lakh
Issued & subscribed
Open charges
₹1.24 Cr
Satisfied ₹14.61 Lakh
Company age
38 yrs
Est. 1988
Employees · EPFO
3
Provident fund records

About Sayora Pharma Private Limited

Data last updated:

Sayora Pharma Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 December 1988 and has been in existence for over 38 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24211CH1988PTC008896. Its GSTIN is 06AACCS0430R1Z9 (Haryana). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.53 Lakh. It is led by directors Devinder Pal Syal (Managing Director) and Rashmi Syal.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at SCO 56 & 57, Next To Gpo Bridge Market Sector – 17 D, Chandigarh, India – 160017.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.23 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹90,053 (net margin 0.4%) and EBITDA of ₹12.81 Lakh (EBITDA margin 5.8%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 7% over five years.

The company has about 3 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Sayora Pharma. As per MCA filings, the company has open charges of ₹1.24 Cr and satisfied charges of ₹14.61 Lakh on record. Court records list 7 cases involving the company, including 3 filed by the company and 4 filed against it; 1 case is pending.

Sayora Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0008293). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sayorapharma.com.

Company details

CIN U24211CH1988PTC008896
Registration Number 008896
Incorporation Date 12 December 1988
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-13-0008293

Recognitions & Rankings of Sayora Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-HR-13-0008293

Contact details

Sayora Pharma Private Limited's registered office is in Chandigarh, Chandigarh. Its website is sayorapharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    SCO 56 & 57, Next To Gpo Bridge Market Sector – 17 D, Chandigarh, India – 160017
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Sayora Pharma Private Limited, buy the company report.

Comprehensive company report
Sayora Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Sayora Pharma operates one associated brand: Sayora Pharma. Each brand links to its own profile.

BrandDescriptionWebsite
Manufacturing and marketing of pharmaceutical products, including eye drops and injections, in India.sayorapharma.com

Business activity

The main business activity of Sayora Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Sayora Pharma Private Limited, buy the company report.

Financials of Sayora Pharma Private Limited

FY 2024 filings available

Sayora Pharma Private Limited reported revenue of ₹2.23 Cr (up 16% YoY) for FY 2024.

Revenue · FY 2024
₹2.23 Cr ▲ 16%
Net profit · FY 2024
₹90,053 margin 0.4%
EBITDA · FY 2024
₹12.81 Lakh margin 5.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 10%
5 years · compounded
▼ 7%
EBITDA CAGR growth
1 year
▲ 17%
3 years · compounded
▼ 2%
5 years · compounded
▼ 7%

Revenue rose 16% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 7%. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹2.23 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹12.81 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹90,053
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin5.8%
Net Profit Margin0.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sayora Pharma Private Limited, buy the company report.

Board of directors of Sayora Pharma Private Limited

Sayora Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Devinder Pal SyalManaging Director12 Dec 198837 Years 10 MonthsCurrent
Rashmi SyalDirector01 Jan 199036 Years 10 MonthsCurrent

Peer comparison

Sayora Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
RMK Pharmaceuticals Private Limited₹2.23 Cr (FY 2023)222.0%Ramachandrapuram, Telangana, India
Mehta Pharmaceuticals Private Limited₹2.23 Cr (FY 2024)-71.0%Amritsar, Punjab, India
Sayora Pharma Private Limitedthis company₹2.23 Cr (FY 2024)₹90,0530.4%16.0%3Chandigarh, India
Swiss Medicare Private Limited₹2.22 Cr (FY 2025)12.0%Sri Ganganagar, Rajasthan, India
Onyx Medicals Private Limited₹2.22 Cr (FY 2025)72.0%Meerut, Uttar Pradesh, India
Larsen Formulations Private Limited₹2.22 Cr (FY 2025)15.0%Mumbai, Maharashtra, India

To see the full peer comparison of Sayora Pharma Private Limited, buy the company report.

Auditor

Sayora Pharma Private Limited is audited by Malhotra Rajiv & Co. for the financial year 2024.

Auditor firmFinancial yearFirm registration number
Malhotra Rajiv & Co.FY 2024024854N

Shareholding

The shareholding of Sayora Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sayora Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.24 Cr
Satisfied charges
₹14.61 Lakh
Breakdown by lending institutions
Canara Bank₹1.24 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
06 May 2025101112538Canara Bank₹24 LakhOpen
25 Sep 200910184912Canara Bank₹1 CrOpen
10 Dec 2024101030022Canara Bank₹8.86 LakhSatisfied
13 Jun 201410508637Canara Bank₹5.75 LakhSatisfied

To see the full charge records of Sayora Pharma Private Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sayora Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Sayora Pharma Private Limited has a workforce of 3 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.

Employee count
3
Active EPFO establishments
1
Employee growth
-25%

GST

Sayora Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
06AACCS0430R1Z9HaryanaActive01 Jul 2017

To see the full GST registrations and return filing status of Sayora Pharma Private Limited, buy the company report.

Recent activity

Sayora Pharma Private Limited has 2 board changes on record since 1988: 2 appointments. The latest: Rashmi Syal was appointed as Director on 01 Jan 1990.

Charges
A charge with Canara Bank of Rs. 100.00 Lakh registered on 25 Sep 2009 with Charge ID 10184912 was modified on 10 Nov 2025.
Charges
A charge registered on 10 Dec 2024 via Charge ID 101030022 with Canara Bank was fully satisfied on 01 Sep 2025.
Charges
A charge with Canara Bank amounted to Rs. 24.00 Lakh with Charge ID 101112538 was registered on 06 May 2025.
Charges
A charge with Canara Bank amounted to Rs. 8.86 Lakh with Charge ID 101030022 was registered on 10 Dec 2024.
AGM
Sayora Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Sayora Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
Charges
A charge registered on 13 Jun 2014 via Charge ID 10508637 with Canara Bank was fully satisfied on 22 Feb 2019.
Charges
A charge with Canara Bank amounted to Rs. 5.75 Lakh with Charge ID 10508637 was registered on 13 Jun 2014.
Charges
A charge with Canara Bank amounted to Rs. 100.00 Lakh with Charge ID 10184912 was registered on 25 Sep 2009.
Appointed
Rashmi Syal was appointed as Director.
Appointed
Devinder Pal Syal was appointed as Managing Director.
Incorporation
12 Dec 1988
Sayora Pharma Private Limited was registered on 12 Dec 1988 with Roc Chandigarh & aged 37 years 10 months as per MCA records.

Frequently asked questions

Sayora Pharma is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 December 1988 (38+ years old) and is registered under CIN U24211CH1988PTC008896.

Sayora Pharma has 2 current directors:

The latest financial statements of Sayora Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Sayora Pharma is 06AACCS0430R1Z9, registered in Haryana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of Sayora Pharma is U24211CH1988PTC008896. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sayora Pharma has 7 court cases on record: 3 filed by the company and 4 filed against it. 1 is pending. Most are in the district courts.

Sayora Pharma was incorporated on 12 December 1988, making it 38+ years old. It is registered with the Registrar of Companies, Chandigarh.

The peers of Sayora Pharma by revenue are RMK Pharmaceuticals Private Limited, Mehta Pharmaceuticals Private Limited, Swiss Medicare Private Limited, Onyx Medicals Private Limited, Larsen Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Rashmi Syal was appointed as Director on 01 Jan 1990. Devinder Pal Syal was appointed as Managing Director on 12 Dec 1988.

Yes, Sayora Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-13-0008293).

Sayora Pharma can be reached through the website sayorapharma.com. Its registered office is in Chandigarh, India.